Paraganglionic pheochromocytoma, rare retroperitoneal tumor

Authors

Keywords:

immunohistochemistry, pheochromocytoma, paraganglioma, retroperitoneal neoplasms.

Abstract

Introduction: Retroperitoneal paraganglionic retroperitoneal pheochromocytoma is a tumor with a biologically benign tendency, although it can be confused with a malignant one; moreover, it causes compression of structures and frequently elevates blood pressure.
Objective: To present a patient with a retroperitoneal paraganglionic pheochromocytoma.
Clinical case: A 33-year-old female patient with a history of hypertension and epilepsy, both controlled. She came to the hospital because of pain in the right hemiabdomen. Imaging findings suggested a retroperitoneal tumor. Extirpation and biopsy were decided for definitive diagnosis, and surgery was performed without complications. It was concluded as a retroperitoneal paraganglionic retroperitoneal pheochromocytoma.
Conclusions: Retroperitoneal paraganglionic retroperitoneal pheochromocytoma is a very rare tumor. The differential diagnosis of any adrenal tumor depends on a thorough interrogation and physical examination, as well as the indication of appropriate diagnostic tools.

Downloads

Download data is not yet available.

References

1. Hofland J, Wouter TZ, Wouter WH. Role of biomarker tests for diagnosis of neuroendocrine tumours. Nature Reviews Endocrinology. 2018 [acceso: 05/06/2023]; 14:656-69. Disponible en: https://www.nature.com/articles/s41574-018-0082-5

2. Araneda G, Poniachik R, Freundlich A, Carreño L, Poniachik J. Tumores hepáticos primarios malignos no hepatocarcinoma ni colangiocarcinoma. Rev. méd. Chile. 2019 [acceso: 05/06/2023]; 147(6):751-4. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000600751&lng=es

3. Lee WK, Lau EW, Duddalwar VA, Stenley AJ. Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings. American Journal of Roentgenolgy. 2018 [acceso: 10/03/2022]; 91(1):198-206. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18562746/

4. Rohena-Quinquilla Iván R, Grant E. Lattin Jr, Wolfman Darcy. Imaging of extranodal genitourinary lymphoma Radiologic Clinics. 2016 [acceso: 10/03/2022]; 54(4):747-64. Disponible en: https://www.radiologic.theclinics.com/article/S0033-8389(16)00041-5/fulltext

5. González Maestro DV, Ríos Reboredo D Ángel, Fouce Calvo DI. Diagnóstico por imagen del linfoma renal. Seram. 2021 [acceso: 10/03/2022]; 1(1):322-31. Disponible en: https://www.piper.espacio-seram.com/index.php/seram/article/view/3852

6. Barreto F, Dall`oglio MF, Srougi M. Renal lymphoma. Atypical presentation of a renal tumor. Int Braz J Urol. 2016 [acceso: 10/03/2022]; 32(2):190-2. Disponible en: https://www.scielo.br/j/ibju/a/D4VDFRfz34X3vfr5GFBLr9Q/?format=pdf&lang=en

7. Polanía Andrade ÁN, Monroy Tovar LF, Alarcón Vargas ÁM, Barrios-Torre JC, Vargas HI. Feocromocitoma. Med Int Mex. 2021 [acceso: 06/06/2022]; 37(2):288-95. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2021/mim212q.pdf

8. Maldonado García EL, Nacud Bezies Yamir A, Gómez Vela CM, Morfín Vela C, Guerra Martínez JC. Neoplasia endocrina múltiple IIA: feocromocitoma bilateral. A propósito de un caso y revisión de la literatura. Rev Fac Med. 2021 [acceso: 06/06/2022]; 64(1):26-31. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0026-17422021000100026&lng=es

9. Penichet-Montoto M, Nassif-Hadad A, Blanco-Molina JJ, Gonzalez A, Piera O. Feocromocitoma. Causa curable de hipertensión arterial. Presentación de un caso y revisión de la literatura. Rev Cubana Med. 2020 [acceso: 06/06/2022]; 19 (4):345-56. Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/1518

10. Avilés Marina R, Cimadevilla Calvo B, Rábago Moriyón JL, Ruiz Andrés N, Del Olmo Ruiloba P. Manejo anestésico de feocromocitoma en paciente con enfermedad de Von Hippel-Lindau. Rev Chilena Anest. 2022 [acceso: 06/06/2022]; 3:335-8. Disponible en: https://revistachilenadeanestesia.cl/PII/revchilanestv5122031222.pdf

11. Céspedes Morón M, Camargo Román R, Rodríguez Gutarra N, Mispireta Castañeda A. Feocromocitoma: enfoque multidisciplinario, consideraciones perioperatorias. Rev Fac Med. Hum. 2021 [acceso: 06/06/2022]; 21(3):674-80. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312021000300674&lng=es

12. Pérez Díaz C, Labrador Falero D M, López González M. Feocromocitoma maligno de presentación retroperitoneal. Rev Ciencias Médicas. 2019 [acceso: 06/06/20226]; 23(3):480-6. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942019000300480&lng=es

Downloads

Published

2023-08-11

How to Cite

1.
Barbosa López Y. Paraganglionic pheochromocytoma, rare retroperitoneal tumor. Rev Cubana Med Milit [Internet]. 2023 Aug. 11 [cited 2025 Jan. 10];52(3):e02302163. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/2163

Issue

Vol. 52 No. 3 (2023): July - september

Section

Case Presentation

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.